Browsing Category
Features
699 posts
What’s Next for the New GSK After Consumer Healthcare Spin-off?
By
GlaxoSmithKline has completed the spin-off of its consumer healthcare business to form a separate stand-alone $11-billion company, Haleon. The move is part of a larger strategic plan by GSK’s CEO Emma Walmsley to drive growth in its core bio/pharmaceuticals business. What is next for the New GSK?
Supplier Relationship Management: Examining the Talent of the Future
By
How are the skillsets for sourcing, procurement, and supply management professionals evolving to meet future talent needs, including digital capabilities? What will be needed for effective supplier relationship management in the future both from pharma companies and suppliers?
Big Pharma’s Manufacturing Investments
By
What have been some key recent investments in manufacturing by the large bio/pharmaceutical companies? What areas, small-molecule APIs, biologics, or drug products, have been attracting the investment dollars? DCAT Value Chain Insights rounds up key projects.